DSpace

King Saud University Repository >
King Saud University >
COLLEGES >
Health Colleges >
College of Pharmacy >
College of Pharmacy >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/3093

Title: Public attitude toward drug technical package inserts in Saudi Arabia
Authors: Abou-Auda, Hisham S.
Gubara, Othman A.
Bawazir, Saleh A.
Al-Khamis, Khalil I.
Al-Yamani, Mohammed JMS
Keywords: Public Attitude
Drug
Package Inserts
Saudi Arabia
Technical
Issue Date: Jul-2003
Publisher: Harvey Whitney Books
Citation: Journal of Phamacy Technology: 19; 209-218
Abstract: OBJECTIVE: To examine public opinion in Saudi Arabia regarding the technical drug package insert (PI) as a source of information and to assess the need for potential changes to the existing format in favor of a more patient-oriented package insert (PPI). DESIGN: A cross-sectional survey was conducted from March through May 1998 by means of a self-administered questionnaire. SETTING: Eighty-four community pharmacies in Riyadh. PARTICIPANTS: Two thousand twenty-nine customers entering community pharmacies in Riyadh were enrolled in this survey. RESULTS: Results of the survey showed that 88% of the respondents read the PI. The motives for reading the PI included the desire to know more about the medication (48.7%), to adhere to the prescription (21.7%), and to decide whether to take the medication (13.1%). From the list of information contained therein, respondents listed indications (47.1%) and adverse drug effects (46.6%) as the principal sections of interest. Respondents overwhelmingly endorsed the PI as a complementary source of drug information to the verbal instructions of the physician and the pharmacist. However, readers did criticize its detail, legibility, and poor graphic illustration. Respondents indicated their desire to see a concise PPI introduced, one that highlights only the most common adverse effects of a drug. It should be written in simple Arabic and include, whenever possible, illustrations to enhance comprehension. CONCLUSIONS: The PI does not have the power to overrule the physician's or pharmacist's instructions. Since some patients may cease taking their medicines if they feel threatened by the adverse effects mentioned in the PI, precautionary statements should be prominently placed in the PI to explain the purpose of mentioning such information and what proper action should be taken by the patient.
URI: http://www.jpharmtechnol.com/abstracts/volume19/July-August/209.html
http://hdl.handle.net/123456789/3093
ISSN: 8755-1225
Appears in Collections:College of Pharmacy

Files in This Item:

File Description SizeFormat
Public Attitude Toward Drug Technical.pdf87.01 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

DSpace Software Copyright © 2002-2007 MIT and Hewlett-Packard - Feedback